The Efficacy and Safety of Bedaquiline in the Treatment of Pulmonary Tuberculosis Patients: A Systematic Review and Meta-Analysis

Background: Bedaquiline (BDQ) has been designated as a Group A drug by the World Health Organization (WHO) for the management of multi-drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). This systematic review and meta-analysis aim to evaluate the efficacy and...

Full description

Bibliographic Details
Main Authors: Enyu Tong, Qian Wu, Yiming Chen, Zhengwei Liu, Mingwu Zhang, Yelei Zhu, Kunyang Wu, Junhang Pan, Jianmin Jiang
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/9/1389